Drug ads and Congress

So we all sighed after the House and Senate passed the Food and Drug Administration bill last week. An article in Friday’s WSJ titled, ‘Media Industry Helped Drug Firms Fight Ad Restraints’ highlights the drug industry

…”found powerful allies among media and advertising firms who were determine to protect one of their biggest and fastest growing advertising category.”

I am happy to participate, once again helping out our clients. As you may know Catalyst online is owned by WPP, the worlds largest (debatable) advertising and marketing company. I know, I know, of course we helped you out, it was also a success for the advertising community. In the US, pharmaceutical companies were the tenth biggest advertiser in 2006, spending $5.3 billion, or 3.5% of the total $149.6 billion US ad market (source: TNS Media Intelligence).

However, there are still many people that were not happy with the changes. There are many out there that believe a moratorium on consumer ads is imperative, especially for a drug that raises ’safety issues.’ I am not sure how the term safety issues is being defined - we all know every drug has some safety issues.

So what is my point you ask? Search marketing, of course. A consumer looking for information on a drug or condition, is that advertising? Yes… maybe, no. Search finds people when they are looking for a particular item at the Moment of Relevance (MOR). As always, I am on my soap box about search marketing. There are so many reasons to invest in search marketing, even political.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netscape
  • NewsVine
  • TailRank
  • StumbleUpon
  • YahooMyWeb
  • Reddit

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*